Catabasis Pharmaceuticals Inc Discuss the Open-Label Extension Eesults from the MoveDMD Trial and the Phase 3 Clinical Trial Pla

4/10/2017 8:30

Llamada en conferencia Catabasis Pharmaceuticals Inc

Catabasis Pharmaceuticals Inc Conference call will be held on 04-oct-2017. During the earnings conference call's session Catabasis Pharmaceuticals Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Catabasis Pharmaceuticals Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on our proprietary Safely Metabolized And Rationally Targeted, or SMART, linker drug discovery platform. Our SMART linker drug discovery platform enables us to engineer product candidates that can simultaneously modulate multiple targets in a disease. Our proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Our primary focus is on treatments for rare diseases. We are also developing other product candidates for the treatment of serious lipid disorders. We have applied our SMART linker drug discovery platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.    
Leer más Llamada en conferencia

Catabasis Pharmaceuticals Inc (CATB)

One Kendall Square, Cambridge Massachusetts 02139, United States